{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:23:48Z","timestamp":1791969828055,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"crossref","award":["2017YFD0501004, 2017YFD0501102"],"award-info":[{"award-number":["2017YFD0501004, 2017YFD0501102"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31600740"],"award-info":[{"award-number":["31600740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10753-021-01449-4","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T04:04:02Z","timestamp":1618891442000},"page":"1724-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["An immuno-blocking agent targeting IL-1\u03b2 and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice"],"prefix":"10.1007","volume":"44","author":[{"given":"Qi","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3373-7506","authenticated-orcid":false,"given":"Jiechao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"1449_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"K Bernard","year":"2011","unstructured":"Bernard, K., G. Agn\u00e8s, and J XR. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307\u2013317.","journal-title":"Nature"},{"key":"1449_CR2","doi-asserted-by":"publisher","first-page":"13507","DOI":"10.1038\/ncomms13507","volume":"7","author":"NT Ventham","year":"2016","unstructured":"Ventham, N.T., N.A. Kennedy, A.T. Adams, R. Kalla, S. Heath, K.R. O'Leary, et al. 2016. Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease. Nature Communications 7: 13507.","journal-title":"Nature Communications"},{"key":"1449_CR3","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","volume":"5","author":"MD Kappelman","year":"2007","unstructured":"Kappelman, M.D., S.L. Rifas-Shiman, K. Kleinman, O. Dan, A. Bousvaros, R.J. Grand, et al. 2007. The prevalence and geographic distribution of Crohn\u2019s disease and ulcerative colitis in the United States. Clinical Gastroenterology and Hepatology 5: 1424\u20131429.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"1449_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1615\/JEnvironPatholToxicolOncol.2014008425","volume":"33","author":"KM Sakthivel","year":"2014","unstructured":"Sakthivel, K.M., and G. Chandrasekaran. 2014. Protective effect of Acacia ferruginea against ulcerative colitis via modulating inflammatory mediators, cytokine profile and NF-\u03baB signal transduction pathways. Journal of Environmental Pathology, Toxicology and Oncology 33: 83\u201398.","journal-title":"Journal of Environmental Pathology, Toxicology and Oncology"},{"key":"1449_CR5","first-page":"465","volume":"10","author":"Q Zhu","year":"2018","unstructured":"Zhu, Qin, P. Zheng, X. Chen, F. Zhou, Q. He, and Y. Yang. 2018. Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23\/IL-17 axis. American Journal of Translational Research 10: 465\u2013473.","journal-title":"American Journal of Translational Research"},{"key":"1449_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ibd.20753","volume":"15","author":"A Philip","year":"2009","unstructured":"Philip, A., N.C. Zachos, N. Thuan, G. Liberty, C. Tian-E, L.S. Conklin, et al. 2009. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflammatory Bowel Diseases 15: 341\u2013352.","journal-title":"Inflammatory Bowel Diseases"},{"key":"1449_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.rvsc.2019.06.012","volume":"125","author":"WJ Song","year":"2019","unstructured":"Song, W.J., Q. Li, M.O. Ryu, A. Nam, J.H. An, Y.C. Jung, J.O. Ahn, and H.Y. Youn. 2019. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice. Research in Veterinary Science 125: 176\u2013184.","journal-title":"Research in Veterinary Science"},{"key":"1449_CR8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.20060285","volume":"203","author":"C Sutton","year":"2006","unstructured":"Sutton, C., C. Brereton, B. Keogh, K.H. Mills, and E.C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. Journal of Experimental Medicine 203: 1685\u20131691.","journal-title":"Journal of Experimental Medicine"},{"key":"1449_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley, J.R. 2008. TNF-mediated inflammatory disease. Journal of Pathology 214: 149\u2013160.","journal-title":"Journal of Pathology"},{"key":"1449_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5114\/aoms.2017.68696","volume":"1","author":"A Wedrychowicz","year":"2018","unstructured":"Wedrychowicz, Andrzej, Przemystaw Tomasik, Andrzej Zajac, et al. 2018. Prognostic value of assessment of stool and serum IL-1\u03b2, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis. Archives of Medical Science 1: 107\u2013114.","journal-title":"Archives of Medical Science"},{"key":"1449_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1124\/jpet.103.057059","volume":"308","author":"S Endres","year":"2004","unstructured":"Endres, S., M. Schoenharting, N. Landauer, M. Dauer, B. Siegmund, et al. 2004. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T cell activation. The Journal of Pharmacology and Experimental Therapeutics 308: 583\u2013590.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"1449_CR12","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","volume":"178","author":"RM Al-Sadi","year":"2007","unstructured":"Al-Sadi, R.M., and T.Y. Ma. 2007. IL-1beta causes an increase in intestinal epithelial tight junction permeability. Journal of Immunology 178: 4641\u20134649.","journal-title":"Journal of Immunology"},{"key":"1449_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1089\/jir.2012.0031","volume":"32","author":"AS Rana","year":"2012","unstructured":"Rana, A.S., G. Shuhong, D. Karol, M.A. Smith, Y. Dongmei, K. Archana, et al. 2012. Mechanism of interleukin-1\u03b2 induced-increase in mouse intestinal permeability in vivo. Journal of Interferon & Cytokine Research 32: 474\u2013484.","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"1449_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fimmu.2018.00025","volume":"9","author":"L Mao","year":"2018","unstructured":"Mao, L., A. Kitani, W. Strober, and I.J. Fuss. 2018. The Role of NLRP3 and IL-1beta in the pathogenesis of inflammatory bowel disease. Frontiers in Immunology 9: 25\u201366.","journal-title":"Frontiers in Immunology"},{"key":"1449_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1084\/jem.20111703","volume":"209","author":"MH Shaw","year":"2012","unstructured":"Shaw, M.H., N. Kamada, Y. Kim, et al. 2012. Microbiota-induced IL-1\u03b2, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. Journal of Experimental Medicine 209: 251\u2013258.","journal-title":"Journal of Experimental Medicine"},{"key":"1449_CR16","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.4049\/jimmunol.179.10.6536","volume":"179","author":"DA Rao","year":"2007","unstructured":"Rao, D.A., K.J. Tracey, and J.S. Pober. 2007. IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. Journal of Immunology 179: 6536\u20136546.","journal-title":"Journal of Immunology"},{"key":"1449_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/1744666X.2014.882232","volume":"10","author":"S Xiaofei","year":"2014","unstructured":"Xiaofei, S., D. Junfeng, G. Wenxian, and Z. Yong. 2014. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance. Expert Review of Clinical Immunology 10: 353\u2013362.","journal-title":"Expert Review of Clinical Immunology"},{"key":"1449_CR18","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","volume":"140","author":"W Strober","year":"2011","unstructured":"Strober, W., and I.J. Fuss. 2011. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756\u20131767.","journal-title":"Gastroenterology"},{"key":"1449_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65\u201370.","journal-title":"Gut"},{"key":"1449_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fimmu.2017.00824","volume":"8","author":"L Ming","year":"2017","unstructured":"Ming, L., W. Bing, S. Xiaotong, et al. 2017. Upregulation of intestinal barrier function in mice with DSS-induced colitis by a defined bacterial consortium is associated with expansion of IL-17A producing gamma delta T cells. Frontiers in Immunology 8: 824.","journal-title":"Frontiers in Immunology"},{"key":"1449_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1365-2036.2011.04599.x","volume":"33","author":"MLA Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet, M.L.A., and L.M. L\u00e9mann. 2011. Review article: remission rates achievable by current therapies for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 33: 870\u2013879.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"1449_CR22","doi-asserted-by":"publisher","first-page":"e0208922","DOI":"10.1371\/journal.pone.0208922","volume":"13","author":"DJ Buurman","year":"2018","unstructured":"Buurman, D.J., T. Blokzijl, E.A.M. Festen, B.T. Pham, K.N. Faber, E. Brouwer, and G. Dijkstra. 2018. Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-\u03b1 biologicals and an Infliximab-biosimilar. PLoS One 13: e0208922.","journal-title":"PLoS One"},{"key":"1449_CR23","first-page":"1","volume":"62","author":"PC Urbano","year":"2018","unstructured":"Urbano, P.C., R. Aguirre-Gamboa, A. Ashikov, et al. 2018. TNFAIP3\/A20 acts as master switch in TNF\u00ce\u00b1 blockade-driven IL-17A expression. The Journal of Allergy and Clinical Immunology 62: 1\u201313.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"1449_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ibd.20753","volume":"15","author":"P Alex","year":"2009","unstructured":"Alex, P., N.C. Zachos, T. Nguyen, L. Gonzales, T.E. Chen, L.S. Conklin, M. Centola, and X. Li. 2009. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflammatory Bowel Diseases 15: 341\u2013352.","journal-title":"Inflammatory Bowel Diseases"},{"key":"1449_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.biopha.2017.02.045","volume":"89","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Q. Wu, Z. Liu, X. Guo, L. Zhou, Y. Wang, L. Song, N. Wang, Q. Zheng, W. Wang, G. Ren, and D. Li. 2017. A recombinant IgG-like bispecific antibody acting as interleukin-1\u03b2 and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis. Biomedicine & Pharmacotherapy 89: 426\u2013437.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1449_CR26","first-page":"465","volume":"10","author":"Q Zhu","year":"2018","unstructured":"Zhu, Q., P. Zheng, X. Chen, F. Zhou, Q. He, and Y. Yang. 2018. Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23\/IL-17 axis. American Journal of Translational Research 10: 465\u2013473.","journal-title":"American Journal of Translational Research"},{"key":"1449_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jnutbio.2004.09.007","volume":"16","author":"HS Oz","year":"2005","unstructured":"Oz, H.S., T.S. Chen, C.J. Mcclain, and W.J. de Villiers. 2005. Antioxidants as novel therapy in a murine model of colitis. Journal of Nutritional Biochemistry 16: 297\u2013304.","journal-title":"Journal of Nutritional Biochemistry"},{"key":"1449_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bcp.2018.06.029","volume":"155","author":"I Daniela","year":"2018","unstructured":"Daniela, I., S. Rosalba, C. Marika, et al. 2018. Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1\u03b2 and IL-18. Biochemical Pharmacology 155: 150\u2013161.","journal-title":"Biochemical Pharmacology"},{"key":"1449_CR29","doi-asserted-by":"publisher","first-page":"A783","DOI":"10.1016\/0016-5085(95)27443-X","volume":"108","author":"G Bioque","year":"1995","unstructured":"Bioque, G., G. Monteleone, J.B.A. Crusius, A. Dominianni, N. Perrotti, P.J. Kostense, S.G.M. Meuwissen, F. Pallone, and A.S. Pe\u00f1a. 1995. Further evidence for a genetic association of interleukin-1 receptor antagonist with ulcerative colitis in a northern and a mediterranean population. Gastroenterology 108: A783.","journal-title":"Gastroenterology"},{"key":"1449_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.gene.6364032","volume":"5","author":"MJ Carter","year":"2004","unstructured":"Carter, M.J., S. Jones, N.J. Camp, A. Cox, J. Mee, B. Warren, G.W. Duff, A.J. Lobo, and F.S. di Giovine. 2004. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes and Immunity 5: 8\u201315.","journal-title":"Genes and Immunity"},{"key":"1449_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","volume":"110","author":"A Ogawa","year":"2004","unstructured":"Ogawa, A., A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clinical Immunology (Orlando) 110: 55\u201362.","journal-title":"Clinical Immunology (Orlando)"},{"key":"1449_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/09546634.2017.1329511","volume":"29","author":"M Hohenberger","year":"2017","unstructured":"Hohenberger, M., L.A. Cardwell, E. Oussedik, et al. 2017. Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease. Journal of Dermatological Treatment 29: 13\u201318.","journal-title":"Journal of Dermatological Treatment"},{"key":"1449_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/apt.15397","volume":"50","author":"A Yamada","year":"2019","unstructured":"Yamada, A., J. Wang, Y. Komaki, F. Komaki, D. Micic, and A. Sakuraba. 2019. Systematic review and meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents. Alimentary Pharmacology & Therapeutics 50: 373\u2013385.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"1449_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12876-019-1067-0","volume":"19","author":"Matthew K Smith, Jay Pai, Paul Beck","year":"2019","unstructured":"Matthew K Smith, Jay Pai, Paul Beck, et al. 2019. Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report. BMC Gastroenterology 19: 162.","journal-title":"BMC Gastroenterology"},{"key":"1449_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-016-1391-6","volume":"94","author":"M Perusina Lanfranca","year":"2016","unstructured":"Perusina Lanfranca, M., Y. Lin, J. Fang, W. Zou, and T. Frankel. 2016. Biological and pathological activities of interleukin-22. Journal of Molecular Medicine 94: 523\u2013534.","journal-title":"Journal of Molecular Medicine"},{"key":"1449_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/gut.2006.090456","volume":"56","author":"F Rieder","year":"2007","unstructured":"Rieder, F., J. Brenmoehl, S. Leeb, J. SchoLmerich, and G. Rogler. 2007. Wound healing and fibrosis in intestinal disease. Gut 56: 130\u2013139.","journal-title":"Gut"},{"key":"1449_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2741\/A428","volume":"4","author":"MK Jones","year":"1999","unstructured":"Jones, M.K., M. Tomikawa, B. Mohajer, and A.S. Tarnawski. 1999. Gastrointestinal mucosal regeneration: role of growth factors. Frontiers in Bioscience 4: 303\u2013309.","journal-title":"Frontiers in Bioscience"},{"key":"1449_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20092121","volume":"207","author":"MS Wilson","year":"2010","unstructured":"Wilson, M.S., S.K. Madala, T.R. Ramalingam, B.R. Gochuico, I.O. Rosas, A.W. Cheever, and T.A. Wynn. 2010. Bleomycin and IL-1\u03b2-mediated pulmonary fibrosis is IL-17A dependent. Journal of Experimental Medicine 207: 535\u2013552.","journal-title":"Journal of Experimental Medicine"},{"key":"1449_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.joca.2004.12.010","volume":"13","author":"N Takahashi","year":"2005","unstructured":"Takahashi, N., K. Rieneck, P.M.V.D. Kraan, et al. 2005. Elucidation of IL-1\/TGF-\u03b2 interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthritis and Cartilage 13: 426\u2013438.","journal-title":"Osteoarthritis and Cartilage"},{"key":"1449_CR40","first-page":"e60067","volume":"151","author":"R Mathur","year":"2019","unstructured":"Mathur, Ramkumar, Mahabub Maraj Alam, Xiao-Feng Zhao, et al. 2019. Mechanistic insight into the development of TNBS-mediated intestinal fibrosis and evaluating the inhibitory effects of rapamycin. Journal of Visualized Experiments 151: e60067.","journal-title":"Journal of Visualized Experiments"},{"key":"1449_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cbin.10916","volume":"42","author":"MC D'Arpino","year":"2018","unstructured":"D'Arpino, M.C., A.G. Fuchs, and Sara S. S\u00e1nchez, et al. 2018. Extracellular matrix remodeling and TGF-\u03b21\/Smad signaling in diabetic colon mucosa. Cell Biology International 42: 443\u2013456.","journal-title":"Cell Biology International"},{"key":"1449_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1165\/rcmb.2009-0318OC","volume":"43","author":"DV Pechkovsky","year":"2010","unstructured":"Pechkovsky, D.V., T.L. Hackett, S.S. An, F. Shaheen, L.A. Murray, and D.A. Knight. 2010. Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-\u03b2 signaling and \u03b1-SMA expression. American Journal of Respiratory Cell and Molecular Biology 43: 641\u2013651.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"1449_CR43","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s10753-017-0614-5","volume":"40","author":"RS Young","year":"2017","unstructured":"Young, Rebecca S., Brody M. Wiles, and Dennis W. McGee. 2017. IL-22 enhances TNF-\u03b1- and IL-1-induced CXCL8 responses by intestinal epithelial cell lines. Inflammation 40: 1726\u20131734.","journal-title":"Inflammation"},{"key":"1449_CR44","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2741\/e463","volume":"4","author":"HA Almenier","year":"2012","unstructured":"Almenier, H.A., H.H. Al Menshawy, M.M. Maher, and G.S. Al. 2012. Oxidative stress and inflammatory bowel disease. Frontiers in Bioscience 4: 1335\u20131344.","journal-title":"Frontiers in Bioscience"},{"key":"1449_CR45","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","volume":"87","author":"K Sinha","year":"2013","unstructured":"Sinha, K., J. Das, P.B. Pal, and P.C. Sil. 2013. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Archives of Toxicology 87: 1157\u20131180.","journal-title":"Archives of Toxicology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01449-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-021-01449-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01449-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T03:41:46Z","timestamp":1632368506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-021-01449-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1007\/s10753-021-01449-4","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in strict accordance with the protocols approved by Animal Care and Use Committee of Materia Medica, P.R. China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}